ETH researchers working with Martin Fussenegger have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.
Alongside cardiovascular disease, cancer has become the top cause of death in industrialised countries. Many of those affected are diagnosed only after the tumour has developed extensively. This often reduces the chance of recovery significantly: the cure rate for prostate cancer is 32 percent and only 11 percent for colon cancer. The ability to detect such tumours reliably and early would not only save lives, but also reduce the need for expensive, stressful treatment.
Researchers working with Martin Fussenegger, Professor at the Department of Biosystems Science and Engineering at ETH Zurich in Basel, have now presented a possible solution for this problem: a synthetic gene network that serves as an early warning system. It recognises the four most common types of cancer – prostate, lung, colon and breast cancer – at a very early stage, namely when the level of calcium in the blood is elevated due to the developing tumour.
Derailed calcium balance triggers melanin production
The early warning system comprises a genetic network that biotechnologists integrate into human body cells, which in turn are inserted into an implant. This encapsulated gene network is then implanted under the skin where it constantly monitors the blood calcium level.
As soon as the calcium level exceeds a particular threshold value over a longer period of time, a signal cascade is triggered that initiates production of the body’s tanning pigment melanin in the genetically modified cells. The skin then forms a brown mole that is visible to the naked eye.
The mole appears long before the cancer becomes detectable through conventional diagnosis. “An implant carrier should then see a doctor for further evaluation after the mole appears,” explains Fussenegger. It is no reason to panic. “The mole does not mean that the person is likely to die soon,” stresses the ETH professor. It simply means that clarification and if necessary treatment are needed.
The researchers used calcium as the indicator of the development of the four types of cancer, as it is regulated strongly in the body. Bones serve as a buffer that can balance out concentration differences. However, when too much calcium is detected in the blood, this may serve as a sign for one of the four cancers.
Early detection increases survival rate
“Early detection increases the chance of survival significantly,” says Fussenegger. For example, if breast cancer is detected early, the chance of recovery is 98 percent; however, if the tumour is diagnosed too late, only one in four women has a good chance of recovery. “Nowadays, people generally go to the doctor only when the tumour begins to cause problems. Unfortunately, by that point it is often too late.”
The implant also has an additional advantage: “It is intended primarily for self-monitoring, making it very cost effective,” explains the ETH professor. However, for those who would prefer not to deal with the constant stress, an implant can also be used that develops a mark visible only under a red light. “This regular check could be carried out by their doctor.”
The disadvantage is that the service life of such an implant is limited, as Fussenegger has found in literature. “Encapsulated living cells last for about a year, according to other studies. After that, they must be inactivated and replaced.”
A reliable prototype
So far, this early warning implant is a prototype; the associated work recently published in the journal Science Translational Medicine is a feasibility study. The researchers have tested their early warning system in a mouse model and on pig skin. It functioned reliably during these tests. Moles developed only when the calcium concentration reached a high level.
The Basel-based scientists still have a long way to go before human testing can begin. “Continued development and clinical trials in particular are laborious and expensive, which we as a research group cannot afford,” says the ETH professor. However, he would like to promote the translation of his developments, so that one day they will lead to applicable products. He estimates that bringing such a cancer diagnosis implant to market maturity will take at least ten years of research and development.
The concept of the “biomedical tattoo”, as Fussenegger describes this new finding, would also be applicable to other gradually developing illnesses, such as neurodegenerative diseases and hormonal disorders. In principle, the researchers could replace the molecular sensor to measure biomarkers other than calcium.
Learn more: An artificial mole as an early warning sign
The Latest on: Synthetic gene network
via Google News
The Latest on: Synthetic gene network
- Rabbit gene blended with ivy makes super-powered air cleaner on December 22, 2018 at 12:52 pm
Researchers at the University of Washington have built a better air cleaner, by introducing a gene known as P450 2e1 into devil ... The team introduced a synthetic version of the rabbit form of 2E1 in... […]
- 'DNA Printing' in the Cloud, Part 1 on December 18, 2018 at 10:02 am
Each product began as a digital "gene of interest ... biotechnology, synthetic biology, computational biology, biological computing, in silico predictive modelling, cybergenomics and bioinformatics. T... […]
- Copycat Cells Command New Powers of Communication on December 10, 2018 at 12:43 am
Recently named Blavatnik National Laureate in Chemistry, Neal Devaraj, along with research colleagues Henrike Niederholtmeyer and Cynthia Chaggan, used materials like clay and plastic to make syntheti... […]
- Artificial mole can be early cancer warning sign: study on April 18, 2018 at 3:06 pm
WASHINGTON, April 18 (Xinhua) -- Swiss researchers have proposed a possible solution for early cancer warning using a synthetic gene network implanted under the skin and a mole might appear if cancer ... […]
- Senti launches to improve cell therapies with synthetic gene circuits on February 27, 2018 at 4:00 am
based Senti Biosciences recently raised $53 million to develop cell and gene therapies controlled by genetic circuits ... After spending more than a decade developing these genetic circuits in the lab ... […]
- UCLA Develops Synthetic 'Gene' to Capture Carbon Emissions on February 11, 2018 at 4:00 pm
Researchers at the University of California, Los Angeles have created a synthetic “gene” they say can capture carbon dioxide emissions. Omar M. Yaghi, a professor of chemistry and biochemistry, has de... […]
- Programming gene and engineered-cell therapies with synthetic biology on February 8, 2018 at 4:00 pm
... build gene circuits that behave as anticipated (79), often requiring many design-build-test iterations before a synthetic gene network meets its performance goals. One common reason is unaccounted ... […]
- Team develops gene circuit design strategy to advance synthetic biology on September 26, 2017 at 12:58 pm
Synthetic circuits and the host form a dynamic ... According to Lu, this work advances the quantitative understanding of gene circuit behaviors, and facilitates the transformation of gene network desi... […]
- Gene Editing Technique Helps Find Cancer’s Weak Spots on March 19, 2017 at 5:00 pm
Network of synthetic-lethal interactions connecting commonly ... of Medicine and Jacobs School of Engineering developed a new method to search for synthetic-lethal gene combinations. The technique, pu... […]
via Bing News